Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07680686
PHASE1
Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
This study will assess how different oral formulations of ubrogepant move through the body in healthy adult participants under fasting and fed conditions.
Official title: A Two-Part, Phase 1, Open-Label, Randomized Study to Evaluate the Relative Bioavailability (Versus Immediate Release Tablet) and Food Effect of a New Orally Disintegrating Tablet Formulation of Ubrogepant in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2026-06-30
Completion Date
2026-10
Last Updated
2026-07-02
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Ubrogepant
IRT Oral Tablet
DRUG
Ubrogepant
ODT Oral Tablet